ACADIAN TIMBER CORP (ADN.CA) Stock Fundamental Analysis

TSX:ADN • CA0042721005

16.83 CAD
-0.09 (-0.53%)
Last: Feb 27, 2026, 07:00 PM
Fundamental Rating

4

Overall ADN gets a fundamental rating of 4 out of 10. We evaluated ADN against 12 industry peers in the Paper & Forest Products industry. ADN scores excellent on profitability, but there are concerns on its financial health. ADN has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • ADN had positive earnings in the past year.
  • In the past year ADN had a positive cash flow from operations.
  • In the past 5 years ADN has always been profitable.
  • Each year in the past 5 years ADN had a positive operating cash flow.
ADN.CA Yearly Net Income VS EBIT VS OCF VS FCFADN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

1.2 Ratios

  • ADN has a Return On Assets of 2.36%. This is amongst the best in the industry. ADN outperforms 83.33% of its industry peers.
  • ADN's Return On Equity of 4.19% is amongst the best of the industry. ADN outperforms 83.33% of its industry peers.
  • ADN has a Return On Invested Capital of 1.63%. This is in the better half of the industry: ADN outperforms 75.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ADN is in line with the industry average of 4.04%.
Industry RankSector Rank
ROA 2.36%
ROE 4.19%
ROIC 1.63%
ROA(3y)5.08%
ROA(5y)4.63%
ROE(3y)9.11%
ROE(5y)8.26%
ROIC(3y)2.69%
ROIC(5y)2.83%
ADN.CA Yearly ROA, ROE, ROICADN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 16.03%, ADN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ADN has grown nicely.
  • ADN has a Operating Margin of 15.01%. This is amongst the best in the industry. ADN outperforms 100.00% of its industry peers.
  • ADN's Operating Margin has declined in the last couple of years.
  • ADN has a better Gross Margin (30.11%) than 100.00% of its industry peers.
  • In the last couple of years the Gross Margin of ADN has remained more or less at the same level.
Industry RankSector Rank
OM 15.01%
PM (TTM) 16.03%
GM 30.11%
OM growth 3Y-3.67%
OM growth 5Y-1.71%
PM growth 3Y-1.44%
PM growth 5Y1.58%
GM growth 3Y0.77%
GM growth 5Y0.08%
ADN.CA Yearly Profit, Operating, Gross MarginsADN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ADN is destroying value.
  • Compared to 1 year ago, ADN has more shares outstanding
  • The number of shares outstanding for ADN has been increased compared to 5 years ago.
  • The debt/assets ratio for ADN is higher compared to a year ago.
ADN.CA Yearly Shares OutstandingADN.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ADN.CA Yearly Total Debt VS Total AssetsADN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • ADN has an Altman-Z score of 1.18. This is a bad value and indicates that ADN is not financially healthy and even has some risk of bankruptcy.
  • ADN has a Altman-Z score of 1.18. This is comparable to the rest of the industry: ADN outperforms 41.67% of its industry peers.
  • ADN has a debt to FCF ratio of 32.89. This is a negative value and a sign of low solvency as ADN would need 32.89 years to pay back of all of its debts.
  • ADN has a better Debt to FCF ratio (32.89) than 66.67% of its industry peers.
  • ADN has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
  • ADN has a better Debt to Equity ratio (0.33) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 32.89
Altman-Z 1.18
ROIC/WACC0.25
WACC6.49%
ADN.CA Yearly LT Debt VS Equity VS FCFADN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 0.96 indicates that ADN may have some problems paying its short term obligations.
  • The Current ratio of ADN (0.96) is worse than 83.33% of its industry peers.
  • A Quick Ratio of 0.88 indicates that ADN may have some problems paying its short term obligations.
  • ADN has a Quick ratio of 0.88. This is comparable to the rest of the industry: ADN outperforms 58.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.88
ADN.CA Yearly Current Assets VS Current LiabilitesADN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1

3. Growth

3.1 Past

  • The earnings per share for ADN have decreased strongly by -48.15% in the last year.
  • ADN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.80% yearly.
  • ADN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -28.86%.
  • ADN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.05% yearly.
EPS 1Y (TTM)-48.15%
EPS 3Y4.63%
EPS 5Y-9.8%
EPS Q2Q%23.08%
Revenue 1Y (TTM)-28.86%
Revenue growth 3Y6.68%
Revenue growth 5Y3.05%
Sales Q2Q%-11.33%

3.2 Future

  • Based on estimates for the next years, ADN will show a decrease in Earnings Per Share. The EPS will decrease by -4.83% on average per year.
  • Based on estimates for the next years, ADN will show a decrease in Revenue. The Revenue will decrease by -3.68% on average per year.
EPS Next Y-52.71%
EPS Next 2Y-22.98%
EPS Next 3Y-10.65%
EPS Next 5Y-4.83%
Revenue Next Year-28.61%
Revenue Next 2Y-2.74%
Revenue Next 3Y-3.68%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ADN.CA Yearly Revenue VS EstimatesADN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
ADN.CA Yearly EPS VS EstimatesADN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 20.04, which indicates a rather expensive current valuation of ADN.
  • Based on the Price/Earnings ratio, ADN is valued cheaper than 83.33% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.10. ADN is valued slightly cheaper when compared to this.
  • A Price/Forward Earnings ratio of 22.52 indicates a rather expensive valuation of ADN.
  • 66.67% of the companies in the same industry are more expensive than ADN, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, ADN is valued at the same level.
Industry RankSector Rank
PE 20.04
Fwd PE 22.52
ADN.CA Price Earnings VS Forward Price EarningsADN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • ADN's Enterprise Value to EBITDA ratio is in line with the industry average.
  • ADN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ADN is cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 91.42
EV/EBITDA 29.12
ADN.CA Per share dataADN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • ADN has an outstanding profitability rating, which may justify a higher PE ratio.
  • ADN's earnings are expected to decrease with -10.65% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-22.98%
EPS Next 3Y-10.65%

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 6.85%, ADN is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.48, ADN pays a better dividend. On top of this ADN pays more dividend than 91.67% of the companies listed in the same industry.
  • ADN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 6.85%

5.2 History

  • The dividend of ADN decreases each year by -10.56%.
  • ADN has paid a dividend for at least 10 years, which is a reliable track record.
  • ADN has decreased its dividend recently.
Dividend Growth(5Y)-10.56%
Div Incr Years1
Div Non Decr Years1
ADN.CA Yearly Dividends per shareADN.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

  • 73.33% of the earnings are spent on dividend by ADN. This is not a sustainable payout ratio.
  • ADN's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP73.33%
EPS Next 2Y-22.98%
EPS Next 3Y-10.65%
ADN.CA Yearly Income VS Free CF VS DividendADN.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M
ADN.CA Dividend Payout.ADN.CA Dividend Payout, showing the Payout Ratio.ADN.CA Dividend Payout.PayoutRetained Earnings

ACADIAN TIMBER CORP

TSX:ADN (2/27/2026, 7:00:00 PM)

16.83

-0.09 (-0.53%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)02-11
Earnings (Next)05-05
Inst Owners8.29%
Inst Owner ChangeN/A
Ins Owners0.7%
Ins Owner ChangeN/A
Market Cap307.82M
Revenue(TTM)85.21M
Net Income(TTM)14.13M
Analysts76.67
Price Target18.11 (7.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.85%
Yearly Dividend0.66
Dividend Growth(5Y)-10.56%
DP73.33%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.32%
Min EPS beat(2)-40.59%
Max EPS beat(2)29.95%
EPS beat(4)2
Avg EPS beat(4)36.33%
Min EPS beat(4)-40.59%
Max EPS beat(4)164.03%
EPS beat(8)5
Avg EPS beat(8)101.8%
EPS beat(12)9
Avg EPS beat(12)176.18%
EPS beat(16)11
Avg EPS beat(16)130.41%
Revenue beat(2)1
Avg Revenue beat(2)-9.79%
Min Revenue beat(2)-31.34%
Max Revenue beat(2)11.76%
Revenue beat(4)1
Avg Revenue beat(4)-7.73%
Min Revenue beat(4)-31.34%
Max Revenue beat(4)11.76%
Revenue beat(8)2
Avg Revenue beat(8)-0.37%
Revenue beat(12)4
Avg Revenue beat(12)-1.15%
Revenue beat(16)6
Avg Revenue beat(16)-0.65%
PT rev (1m)0%
PT rev (3m)-8.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 20.04
Fwd PE 22.52
P/S 3.49
P/FCF 91.42
P/OCF 44.04
P/B 0.91
P/tB 0.93
EV/EBITDA 29.12
EPS(TTM)0.84
EY4.99%
EPS(NY)0.75
Fwd EY4.44%
FCF(TTM)0.18
FCFY1.09%
OCF(TTM)0.38
OCFY2.27%
SpS4.82
BVpS18.41
TBVpS18.07
PEG (NY)N/A
PEG (5Y)N/A
Graham Number18.65
Profitability
Industry RankSector Rank
ROA 2.36%
ROE 4.19%
ROCE 2.27%
ROIC 1.63%
ROICexc 1.64%
ROICexgc 1.65%
OM 15.01%
PM (TTM) 16.03%
GM 30.11%
FCFM 3.82%
ROA(3y)5.08%
ROA(5y)4.63%
ROE(3y)9.11%
ROE(5y)8.26%
ROIC(3y)2.69%
ROIC(5y)2.83%
ROICexc(3y)2.73%
ROICexc(5y)2.88%
ROICexgc(3y)2.76%
ROICexgc(5y)2.92%
ROCE(3y)3.75%
ROCE(5y)3.95%
ROICexgc growth 3Y0.45%
ROICexgc growth 5Y-5.14%
ROICexc growth 3Y0.47%
ROICexc growth 5Y-5.06%
OM growth 3Y-3.67%
OM growth 5Y-1.71%
PM growth 3Y-1.44%
PM growth 5Y1.58%
GM growth 3Y0.77%
GM growth 5Y0.08%
F-Score3
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 32.89
Debt/EBITDA 7.67
Cap/Depr 328.17%
Cap/Sales 4.11%
Interest Coverage 3.75
Cash Conversion 48.76%
Profit Quality 23.84%
Current Ratio 0.96
Quick Ratio 0.88
Altman-Z 1.18
F-Score3
WACC6.49%
ROIC/WACC0.25
Cap/Depr(3y)780.67%
Cap/Depr(5y)518.79%
Cap/Sales(3y)3.37%
Cap/Sales(5y)2.17%
Profit Quality(3y)61.15%
Profit Quality(5y)72.04%
High Growth Momentum
Growth
EPS 1Y (TTM)-48.15%
EPS 3Y4.63%
EPS 5Y-9.8%
EPS Q2Q%23.08%
EPS Next Y-52.71%
EPS Next 2Y-22.98%
EPS Next 3Y-10.65%
EPS Next 5Y-4.83%
Revenue 1Y (TTM)-28.86%
Revenue growth 3Y6.68%
Revenue growth 5Y3.05%
Sales Q2Q%-11.33%
Revenue Next Year-28.61%
Revenue Next 2Y-2.74%
Revenue Next 3Y-3.68%
Revenue Next 5YN/A
EBIT growth 1Y-48.28%
EBIT growth 3Y2.77%
EBIT growth 5Y1.28%
EBIT Next Year-37.55%
EBIT Next 3Y3.4%
EBIT Next 5YN/A
FCF growth 1Y-70.57%
FCF growth 3Y13.98%
FCF growth 5YN/A
OCF growth 1Y-41.26%
OCF growth 3Y28.01%
OCF growth 5YN/A

ACADIAN TIMBER CORP / ADN.CA FAQ

What is the ChartMill fundamental rating of ACADIAN TIMBER CORP (ADN.CA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ADN.CA.


Can you provide the valuation status for ACADIAN TIMBER CORP?

ChartMill assigns a valuation rating of 4 / 10 to ACADIAN TIMBER CORP (ADN.CA). This can be considered as Fairly Valued.


How profitable is ACADIAN TIMBER CORP (ADN.CA) stock?

ACADIAN TIMBER CORP (ADN.CA) has a profitability rating of 8 / 10.


What are the PE and PB ratios of ACADIAN TIMBER CORP (ADN.CA) stock?

The Price/Earnings (PE) ratio for ACADIAN TIMBER CORP (ADN.CA) is 20.04 and the Price/Book (PB) ratio is 0.91.


What is the financial health of ACADIAN TIMBER CORP (ADN.CA) stock?

The financial health rating of ACADIAN TIMBER CORP (ADN.CA) is 2 / 10.